Bắt đầu
ABBVIE INC CEDEAR EA 10 REP 1 COM(USD)ABBVIE INC CEDEAR EA 10 REP 1 COM(USD)ABBVIE INC CEDEAR EA 10 REP 1 COM(USD)

ABBVIE INC CEDEAR EA 10 REP 1 COM(USD)

Không có giao dịch
Xem siêu biểu đồ
Tổng quan Tài chính Ý tưởng Thảo luận Kỹ thuật Các chỉ số có tính thời vụ
Trái phiếu

Trái phiếu ABBVD

Sau đây là danh sách trái phiếu doanh nghiệp ABBVIE INC CEDEAR EA 10 REP 1 COM(USD). Các nhà đầu tư thường lựa chọn trái phiếu của công ty vì tính ổn định cao hơn trong thời điểm thị trường biến động. Nghiên cứu giá cả, lợi suất và các số liệu thống kê khác và tìm khoản đầu tư đáng tin cậy.
Mã
Lợi suất đáo hạn %
Khối lượng
Giá %
Phiếu giảm giá %
Ngày đáo hạn
Giá trị dư nợ
Giá trị khuôn mặt
Giá trị mệnh giá tối thiểu
Bên phát hành
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
6.57%600 K84.44%4.55%2035-03-15107.646 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6.56%15 K79.63%4.85%2044-06-1565.232 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
6.44%10 K79.20%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6.31%5 K80.72%4.63%2042-10-0167.493 M USD1,000.00 USD2,000.00 USDActavis, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5.71%50 K89.00%3.20%2029-11-2162.515 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5.60%16.456 M98.07%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5.54%089.07%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5.53%156 K91.37%4.85%2044-06-151.008 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5.50%43 K90.94%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5.50%085.80%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5.49%570 K89.63%4.63%2042-10-01389.217 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5.49%22.277 M98.56%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5.46%90 K90.75%4.75%2045-03-15827.091 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5.45%1.34 M98.71%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5.40%31.367 M82.77%4.25%2049-11-215.745 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5.40%1.443 M87.92%4.40%2042-11-062.599 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5.30%4.923 M86.54%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5.25%091.57%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5.20%094.24%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5.13%488 K95.26%4.55%2035-03-151.681 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
5.11%6.573 M99.53%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4.94%10.097 M100.05%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4.80%7.816 M92.85%3.20%2029-11-215.437 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AA5QDALLERGAN FNDG 15/25
4.76%099.06%3.80%2025-03-15130.225 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4.76%13.33 M100.15%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
4.76%096.53%2.95%2026-11-219.245 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4.64%097.92%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4.64%8.836 M98.59%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4.62%7.135 M100.40%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4.56%3.663 M96.91%2.95%2026-11-213.991 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4.33%099.29%3.60%2025-05-143.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4.21%1.55 M99.60%3.80%2025-03-152.889 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
3.78%095.69%2.63%2028-11-1572.107 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
XXS162262122ALLERGAN FNDG 17/29
3.77%093.12%2.13%2029-06-0136.462 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3.07%0121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3.03%0126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2.96%0128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2.89%089.58%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2.77%097.23%2.13%2029-06-01506.088 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2.75%099.53%2.63%2028-11-15427.793 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024
2.70%2.58 M99.90%2.60%2024-11-213.739 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS152090781ABBVIE 16/28
2.68%097.89%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2.52%094.87%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2.01%0123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
1.63%0102.15%3.80%2025-03-151.268 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024
−3.63%0106.34%2.60%2024-11-2110.86 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3.80%2025-03-15—1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.